Pharmaceutical shares being spotlighted on higher hope of new drugs
The share prices of Ilyang Pharmaceutical rose to 60 percent on January 5 compared with its shares in December, by expectations that its new drug for myelogenous leukemia m...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
